ASO Author Reflections: Regulation of Chemoresistance in Pancreatic Ductal Adenocarcinoma by Scavenger Receptor CD36

Ann Surg Oncol. 2020 Feb;27(2):620-621. doi: 10.1245/s10434-019-08022-2. Epub 2019 Oct 28.

Authors

Masahiko Kubo¹, Hidetoshi Eguchi²

Affiliations

¹ Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University Hospital, Osaka University, Suita, Osaka, Japan.
² Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University Hospital, Osaka University, Suita, Osaka, Japan. heguchi@gesurg.med.osaka-u.ac.jp.

PMID: 31659646
DOI: 10.1245/s10434-019-08022-2

No abstract available

MeSH terms

Antimetabolites, Antineoplastic / pharmacology*
CD36 Antigens / antagonists & inhibitors
CD36 Antigens / metabolism*
Carcinoma, Pancreatic Ductal / drug therapy*
Carcinoma, Pancreatic Ductal / metabolism
Carcinoma, Pancreatic Ductal / pathology
Deoxycytidine / analogs & derivatives*
Deoxycytidine / pharmacology
Drug Resistance, Neoplasm*
Gemcitabine
Humans
Pancreatic Neoplasms / drug therapy*
Pancreatic Neoplasms / metabolism
Pancreatic Neoplasms / pathology
Prognosis

Substances

Antimetabolites, Antineoplastic
CD36 Antigens
CD36 protein, human
Deoxycytidine
Gemcitabine